Post-treatment features (A) Pathological response according to... | Download Table
The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression
Increased Frequency of CD4+ Cells Expressing CD161 in Cancer Patients | Clinical Cancer Research
Patient Characteristics | Download Table
Unebenheit Tragen Mona Lisa vintage balenciaga dress Samstag Gewissenhaft Antike
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
KLK6 promotes survival of Jurkat T cells in part by slowing the... | Download Scientific Diagram
Correlation between CEACAM19 mRNA expression levels in breast tumors... | Download Scientific Diagram
Increased Frequency of CD4+ Cells Expressing CD161 in Cancer Patients | Clinical Cancer Research
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
CEACAM19 mRNA expression in paired breast tissue samples. Black boxes... | Download Scientific Diagram
Type 1 T cells (IFN-γ producing) are decreased with alefacept therapy.... | Download Scientific Diagram
Increased Frequency of CD4+ Cells Expressing CD161 in Cancer Patients | Clinical Cancer Research
Increased Frequency of CD4+ Cells Expressing CD161 in Cancer Patients | Clinical Cancer Research
Increased Frequency of CD4+ Cells Expressing CD161 in Cancer Patients | Clinical Cancer Research
Ioannis Missitzis's research works | Άγιος Σάββας Αντικαρκινικό Νοσοκομείο, Athens and other places
The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression
A) On low power examination, MPC is more cellular peripherally (red... | Download Scientific Diagram
Identification of a Novel Immunogenic HLA-A*0201-Binding Epitope of HER-2/neu with Potent Antitumor Properties | The Journal of Immunology
The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression
George DEDOUSSIS | Professor of cellular and molecular biology | PhD | Harokopio University, Kallithéa | HUA | Department of Nutrition and Dietetics - Page 5
Patients with pathological response have longer TTR [48 months (17–84)]... | Download Scientific Diagram
Cureus | Matrix-producing Breast Carcinoma: A Rare Subtype of Metaplastic Breast Carcinoma
CANCER IMMUNOSCORING | Sonia A Perez | 2 updates | 11 publications | Research Project
Relative quantification of the CEACAM19 expression via real-time PCR.... | Download Scientific Diagram